-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GGbIZ62WwQ8gykVPt3O2pJkTH+MjFKVsvqcevhOsLD2kKaO/VGfHpYVSnTB0SyA3 eLCargEndI01fB9LJ/EVAw== 0000950103-01-501213.txt : 20010719 0000950103-01-501213.hdr.sgml : 20010719 ACCESSION NUMBER: 0000950103-01-501213 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010731 FILED AS OF DATE: 20010718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABN AMRO BANK NV CENTRAL INDEX KEY: 0000897878 STANDARD INDUSTRIAL CLASSIFICATION: COMMERCIAL BANKS, NEC [6029] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: SEC FILE NUMBER: 001-16519 FILM NUMBER: 1683573 BUSINESS ADDRESS: STREET 1: FOPPINGADREEF 22 STREET 2: 1102 BS AMSTERDAM, ZUID OOST CITY: THE NETHERLANDS STATE: P7 BUSINESS PHONE: 0113120628 MAIL ADDRESS: STREET 1: FOPPINGADREEF 22 STREET 2: 1102 BS AMSTERDAM, ZUID OOST CITY: THE NETHERLANDS STATE: P7 6-K 1 jul1801_6k.txt ================================================================================ FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------- REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 or 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF JULY, 2001 ------------------------- ABN AMRO BANK N.V. (Translation of Registrant's name into English) ------------------------- THE NETHERLANDS (Jurisdiction of Incorporation) Gustav Mahlerlaan 10, 1082 PP Amsterdam, The Netherlands (Address of principal executive offices) ------------------------- [Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:] FORM 20-F X FORM 40-F --- --- [Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934.] YES NO X --- --- [If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):] Not applicable The Information contained in this Report is incorporated by reference into Registration Statement No. 333-49198. ================================================================================ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ABN AMRO BANK N.V. Dated: July 10, 2001 By: /s/ Mark Egert ----------------------------- Name: Mark Egert Title: Attorney-in-fact By: /s/ Robert J. Mulligan, Jr. ----------------------------- Name: Robert J. Mulligan, Jr. Title: Attorney-in-fact ABN AMRO BANK N.V. TABLE OF CONTENTS Sequential Item Page Number - ---- ----------- 1. Form of New Agents Supplemental Agreement dated July __, 2001.. 3 EX-1 2 jul1801_ex01.txt ABN AMRO BANK N.V. UP TO $500,000,000 MEDIUM-TERM NOTES DUE NINE MONTHS OR MORE FROM DATE OF ISSUE NEW AGENTS SUPPLEMENTAL AGREEMENT July __, 2001 ABN AMRO Financial Services, Inc. 1290 Avenue of the Americas New York, NY 10104 First Institutional Securities, L.L.C. 3 Garret Mountain Plaza West Paterson, NJ 07422 H&R Block Financial Advisors 751 Griswold Street Detroit, MI 48226 J.J.B. Hilliard W.L. Lyons, Inc. Hilliard Lyons Center Louisville, KY 40202 Ladies and Gentlemen: We refer to the Distribution Agreement dated November 27, 2000 entered into in respect of the issue and sale from time to time by ABN AMRO Bank N.V. (the "Company") of its Medium-Term Notes described therein (such agreement, as amended from time to time, the "Agreement"), a copy of which has been heretofore supplied to you. We invite you to become an Agent upon the terms of such Agreement, as modified hereby, with respect to the issue and sale of the Company's 11.00% Reverse Exchangeable Securities due July 18, 2002 linked to common stock of Pfizer Inc. (the "Offering"). Your appointment as Agents pursuant to this letter shall only be with respect to the Offering and the terms "you", "your" and "Agents" in the Agreement shall include, as they relate to the Offering, each of ABN AMRO Financial Services, Inc., First Institutional Securities, L.L.C., H&R Block Financial Advisors, and J.J.B. Hilliard W.L. Lyons, Inc. This letter is governed by, and shall be construed in accordance with, the laws of the State of New York, without giving effect to the conflict of laws provisions thereof. Please return to us a copy of this letter signed by an authorized signatory whereupon you will become an Agent under the Agreement for purposes of the Offering. This letter may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same letter. Very truly yours, ABN AMRO BANK N.V. By: --------------------------- Name: Title: By: --------------------------- Name: Title: ABN AMRO INCORPORATED By: --------------------------- Name: Title: Accepted and Agreed: ABN AMRO FINANCIAL SERVICES, INC. By: ----------------------------------- Name: Title: FIRST INSTITUTIONAL SECURITIES, L.L.C. By: ----------------------------------- Name: Title: H&R BLOCK FINANCIAL ADVISORS By: ----------------------------------- Name: Title: J.J.B. HILLIARD W.L. LYONS, INC. By: ----------------------------------- Name: Title: -----END PRIVACY-ENHANCED MESSAGE-----